Nureca Limited — Important, 24-01-2025: General Updates

**Financial Highlights:** In Q3 FY25, Nureca reported a GMV of INR 425 Mn, marking a 23% year-over-year growth. Revenue from operations reached INR 265 Mn, representing an 18% increase compared to the previous year. However, the profit after tax showed a decline, landing at INR -25 Mn, reflecting a significant year-over-year drop. The company remains debt-free and holds a strong liquidity position.

**Strategic Initiatives and Growth Drivers:** The appointment of Mr. Vivek Gupta as Chief Officer Sales and Supply Chain is set to enhance operational efficiency and drive revenue growth. The new partnership with Zepto aims to improve product availability and customer satisfaction. Short-term strategic plans include expanding the online product range, establishing a pan-India sales network, and leveraging exports and corporate sales.

**Business Developments:** Nureca launched two new products in Q3 FY25, further diversifying its portfolio. The company's focus on quick commerce and an extensive distribution network are expected to bolster growth.

**Market Position and Competitive Advantage:** Nureca is recognized as a leader in the home healthcare market, with strong brand recognition and a robust omni-channel platform. The company prides itself on a curated product design and supply chain, creating substantial barriers to entry.

**Investor Implications:** The outlook remains positive as Nureca's strategic initiatives aim for significant topline growth in FY26. Investors should watch for continued expansion and product innovation, which could enhance market positioning and profitability.